Leishmania promastigotes induce cytokine secretion in macrophages through the degradation of synaptotagmin XI

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2363-2372

  Arango Duque, Guillermo ^a,b   Fukuda, Mitsunori ^c   Turco, Salvatore J ^d   Stäger, Simona ^a,b   Descoteaux, Albert ^a,b  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b Department of Microbiology and Immunology   (Canada)

^c TOHOKU UNIVERSITY   (Japan)

^d UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LIPOPHOSPHOGLYCAN; METALLOPROTEINASE; PROTEIN GP63; SMALL INTERFERING RNA; SYNAPTOTAGMIN; SYNAPTOTAGMIN XI; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; GLYCOPROTEIN GP63, LEISHMANIA; SYT11 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNE RESPONSE; INFLAMMATION; LEISHMANIA; LEISHMANIASIS; MACROPHAGE; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PROMASTIGOTE; PROTEIN DEGRADATION; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; GENETICS; HAMSTER; IMMUNOLOGY; PARASITOLOGY; PATHOLOGY; PERITONEUM MACROPHAGE;

ANIMALS; CELL LINE; CRICETINAE; FEMALE; INTERLEUKIN-6; LEISHMANIA; LEISHMANIASIS; MACROPHAGES, PERITONEAL; METALLOENDOPEPTIDASES; MICE; MICE, INBRED BALB C; MONOCYTES; SYNAPTOTAGMINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84907021016     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303043     Document Type: Article

References (64)

1. Alvar, J., I. D. Vélez, C. Bern, M. Herrero, P. Desjeux, J. Cano, J. Jannin, and M. den Boer, WHO Leishmaniasis Control Team. 2012. Leishmaniasis worldwide and global estimates of its incidence. PLoS One 7: e35671.
2. Huber, C., and G. Stingl. 1981. Macrophages in the regulation of immunity. Haematol. Blood Transfus. 27: 31-37.
3. Huynh, K. K., J. G. Kay, J. L. Stow, and S. Grinstein. 2007. Fusion, fission, and secretion during phagocytosis. Physiology 22: 366-372.
4. Alix, E., S. Mukherjee, and C. R. Roy. 2011. Subversion of membrane transport pathways by vacuolar pathogens. J. Cell Biol. 195: 943-952.
5. Flannagan, R. S., G. Cosío, and S. Grinstein. 2009. Antimicrobial mechanisms of phagocytes and bacterial evasion strategies. Nat. Rev. Microbiol. 7: 355-366.
6. Unanue, E. R., D. I. Beller, J. Calderon, J. M. Kiely, and M. J. Stadecker. 1976. Regulation of immunity and inflammation by mediators from macrophages. Am. J. Pathol. 85: 465-478.
7. Stow, J. L., P. C. Low, C. Offenhäuser, and D. Sangermani. 2009. Cytokine secretion in macrophages and other cells: pathways and mediators. Immunobiology 214: 601-612.
8. Turco, S. J., and A. Descoteaux. 1992. The lipophosphoglycan of Leishmania parasites. Annu. Rev. Microbiol. 46: 65-94.
9. Matte, C., and M. Olivier. 2002. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J. Infect. Dis. 185: 673-681.
10. Joshi, P. B., B. L. Kelly, S. Kamhawi, D. L. Sacks, and W. R. McMaster. 2002. Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor. Mol. Biochem. Parasitol. 120: 33-40.
11. Olivier, M., V. D. Atayde, A. Isnard, K. Hassani, and M. T. Shio. 2012. Leishmania virulence factors: focus on the metalloprotease GP63. Microbes Infect. 14: 1377-1389.
12. Moradin, N., and A. Descoteaux. 2012. Leishmania promastigotes: building a safe niche within macrophages. Front. Cell. Infect. Microbiol. 2: 121.
13. Yao, C. 2010. Major surface protease of trypanosomatids: one size fits all? Infect. Immun. 78: 22-31.
14. Gómez, M. A., I. Contreras, M. Hallé, M. L. Tremblay, R. W. McMaster, and M. Olivier. 2009. Leishmania GP63 alters host signaling through cleavageactivated protein tyrosine phosphatases. Sci. Signal. 2: ra58.
15. Jaramillo, M., M. A. Gómez, O. Larsson, M. T. Shio, I. Topisirovic, I. Contreras, R. Luxenburg, A. Rosenfeld, R. Colina, R.W. McMaster, et al. 2011. Leishmania repression of host translation through mTOR cleavage is required for parasite survival and infection. Cell Host Microbe 9: 331-341.
16. Hallé, M., M. A. Gómez, M. Stuible, H. Shimizu, W. R. McMaster, M. Olivier, and M. L. Tremblay. 2009. The Leishmania surface protease GP63 cleaves multiple intracellular proteins and actively participates in p38 mitogen-activated protein kinase inactivation. J. Biol. Chem. 284: 6893-6908.
17. Contreras, I., M. A. Gómez, O. Nguyen, M. T. Shio, R. W. McMaster, and M. Olivier. 2010. Leishmania-induced inactivation of the macrophage transcription factor AP-1 is mediated by the parasite metalloprotease GP63. PLoS Pathog. 6: e1001148.
18. Matheoud, D., N. Moradin, A. Bellemare-Pelletier, M. T. Shio, W. J. Hong, M. Olivier, E. Gagnon, M. Desjardins, and A. Descoteaux. 2013. Leishmania evades host immunity by inhibiting antigen cross-presentation through direct cleavage of the SNARE VAMP8. Cell Host Microbe 14: 15-25.
19. Ghosh, J., M. Bose, S. Roy, and S. N. Bhattacharyya. 2013. Leishmania donovani targets Dicer1 to downregulate miR-122, lower serum cholesterol, and facilitate murine liver infection. Cell Host Microbe 13: 277-288.
20. Descoteaux, A., N. Moradin, and G. Arango Duque. 2013. Leishmania dices away cholesterol for survival. Cell Host Microbe 13: 245-247.
21. Descoteaux, A., and S. J. Turco. 2002. Functional aspects of the Leishmania donovani lipophosphoglycan during macrophage infection. Microbes Infect. 4: 975-981.
22. Desjardins, M., and A. Descoteaux. 1997. Inhibition of phagolysosomal biogenesis by the Leishmania lipophosphoglycan. J. Exp. Med. 185: 2061-2068.
23. Vinet, A. F., M. Fukuda, S. J. Turco, and A. Descoteaux. 2009. The Leishmania donovani lipophosphoglycan excludes the vesicular proton-ATPase from phagosomes by impairing the recruitment of synaptotagmin V. PLoS Pathog. 5: e1000628.
24. Vinet, A. F., S. Jananji, S. J. Turco, M. Fukuda, and A. Descoteaux. 2011. Exclusion of synaptotagmin V at the phagocytic cup by Leishmania donovani lipophosphoglycan results in decreased promastigote internalization. Microbiology 157: 2619-2628.
25. Pang, Z. P., and T. C. Südhof. 2010. Cell biology of Ca2+-triggered exocytosis. Curr. Opin. Cell Biol. 22: 496-505.
26. Arango Duque, G., M. Fukuda, and A. Descoteaux. 2013. Synaptotagmin XI regulates phagocytosis and cytokine secretion in macrophages. J. Immunol. 190: 1737-1745.
27. Vinet, A. F., M. Fukuda, and A. Descoteaux. 2008. The exocytosis regulator synaptotagmin V controls phagocytosis in macrophages. J. Immunol. 181: 5289-295.
28. Beutler, B. A. 1999. The role of tumor necrosis factor in health and disease. J. Rheumatol. Suppl. 57: 16-21.
29. Caler, E. V., S. Chakrabarti, K. T. Fowler, S. Rao, and N. W. Andrews. 2001. The Exocytosis-regulatory protein synaptotagmin VII mediates cell invasion by Trypanosoma cruzi. J. Exp. Med. 193: 1097-1104.
30. Murray, R. Z., J. G. Kay, D. G. Sangermani, and J. L. Stow. 2005. A role for the phagosome in cytokine secretion. Science 310: 1492-1495.
31. Griffin, G. K., G. Newton, M. L. Tarrio, D. X. Bu, E. Maganto-Garcia, V. Azcutia, P. Alcaide, N. Grabie, F. W. Luscinskas, K. J. Croce, and A. H. Lichtman. 2012. IL-17 and TNF-α sustain neutrophil recruitment during inflammation through synergistic effects on endothelial activation. J. Immunol. 188: 6287-6299.
32. Jones, M. R., L. J. Quinton, B. T. Simms, M. M. Lupa, M. S. Kogan, and J. P. Mizgerd. 2006. Roles of interleukin-6 in activation of STAT proteins and recruitment of neutrophils during Escherichia coli pneumonia. J. Infect. Dis. 193: 360-369.
33. Biswas, P., F. Delfanti, S. Bernasconi, M. Mengozzi, M. Cota, N. Polentarutti, A. Mantovani, A. Lazzarin, S. Sozzani, and G. Poli. 1998. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91: 258-265.
34. Vieira, S. M., H. P. Lemos, R. Grespan, M. H. Napimoga, D. Dal-Secco, A. Freitas, T. M. Cunha, W. A. Verri, Jr., D. A. Souza-Junior, M. C. Jamur, et al. 2009. A crucial role for TNF-α in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5. Br. J. Pharmacol. 158: 779-789.
35. Gonçalves, R., X. Zhang, H. Cohen, A. Debrabant, and D. M. Mosser. 2011. Platelet activation attracts a subpopulation of effector monocytes to sites of Leishmania major infection. J. Exp. Med. 208: 1253-1265.
36. Ribeiro-Gomes, F. L., E. H. Roma, M. B. H. Carneiro, N. A. Doria, D. L. Sacks, and N. C. Peters. 2014. Site dependent recruitment of inflammatory cells determines the effective dose of Leishmania major. Infect. Immun. 82: 2713-2727.
37. Peters, N. C., J. G. Egen, N. Secundino, A. Debrabant, N. Kimblin, S. Kamhawi, P. Lawyer, M. P. Fay, R. N. Germain, and D. Sacks. 2008. In vivo imaging reveals an essential role for neutrophils in leishmaniasis transmitted by sand flies. Science 321: 970-974.
38. Wang, Z., and E. R. Chapman. 2010. Rat and Drosophila synaptotagmin 4 have opposite effects during SNARE-catalyzed membrane fusion. J. Biol. Chem. 285: 30759-30766.
39. Arena, A., A. B. Capozza, D. Delfino, and D. Iannello. 1997. Production of TNF α and interleukin 6 by differentiated U937 cells infected with Leishmania major. New Microbiol. 20: 233-240.
40. Lapara, N. J., III, and B. L. Kelly. 2010. Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania. J. Inflamm. 7: 8.
41. Wenzel, U. A., E. Bank, C. Florian, S. Förster, N. Zimara, J. Steinacker, M. Klinger, N. Reiling, U. Ritter, and G. van Zandbergen. 2012. Leishmania major parasite stage-dependent host cell invasion and immune evasion. FASEB J. 26: 29-39.
42. Karam, M. C., H. G. Hamdan, N. A. Abi Chedid, K. B. Bodman-Smith, L. J. Eales-Reynolds, and G. M. Baroody. 2006. Leishmania major: low infection dose causes short-lived hyperalgesia and cytokines upregulation in mice. Exp. Parasitol. 113: 168-173.
43. Tolson, D. L., S. J. Turco, R. P. Beecroft, and T. W. Pearson. 1989. The immunochemical structure and surface arrangement of Leishmania donovani lipophosphoglycan determined using monoclonal antibodies. Mol. Biochem. Parasitol. 35: 109-118.
44. Button, L. L., G. Wilson, C. R. Astell, and W. R. McMaster. 1993. Recombinant Leishmania surface glycoprotein GP63 is secreted in the baculovirus expression system as a latent metalloproteinase. Gene 134: 75-81.
45. Macdonald, M. H., C. J. Morrison, and W. R. McMaster. 1995. Analysis of the active site and activation mechanism of the Leishmania surface metalloproteinase GP63. Biochim. Biophys. Acta 1253: 199-207.
46. Fukuda, M., and K. Mikoshiba. 1999. A novel alternatively spliced variant of synaptotagmin VI lacking a transmembrane domain: implications for distinct functions of the two isoforms. J. Biol. Chem. 274: 31428-31434.
47. Itoh, T., and M. Fukuda. 2006. Identification of EPI64 as a GTPase-activating protein specific for Rab27A. J. Biol. Chem. 281: 31823-31831.
48. Descoteaux, A., and G. Matlashewski. 1989. c-fos and tumor necrosis factor gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 9: 5223-5227.
49. Reiner, N. E. 1982. Host-parasite relationship in murine leishmaniasis: pathophysiological and immunological changes. Infect. Immun. 38: 1223-1230.
50. Flandin, J. F., F. Chano, and A. Descoteaux. 2006. RNA interference reveals a role for TLR2 and TLR3 in the recognition of Leishmania donovani promastigotes by interferon-g-primed macrophages. Eur. J. Immunol. 36: 411-420.
51. Lodge, R., T. O. Diallo, and A. Descoteaux. 2006. Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane. Cell. Microbiol. 8: 1922-1931.
52. Orlandi, P. A., Jr., and S. J. Turco. 1987. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan. J. Biol. Chem. 262: 10384-10391.
53. Russo, D. M., S. J. Turco, J. M. Burns, Jr., and S. G. Reed. 1992. Stimulation of human T lymphocytes by Leishmania lipophosphoglycan-associated proteins. J. Immunol. 148: 202-207.
54. Chen, A. L., K. A. Johnson, J. K. Lee, C. Sütterlin, and M. Tan. 2012. CPAF: a Chlamydial protease in search of an authentic substrate. PLoS Pathog. 8: e1002842.
55. Paun, A., R. Bankoti, T. Joshi, P. M. Pitha, and S. Stäger. 2011. Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection. PLoS Pathog. 7: e1001246.
56. Hsiao, C.-H. C., C. Yao, P. Storlie, J. E. Donelson, and M. E. Wilson. 2008. The major surface protease (MSP or GP63) in the intracellular amastigote stage of Leishmania chagasi. Mol. Biochem. Parasitol. 157: 148-159.
57. Campbell, D. A., U. Kurath, and J. Fleischmann. 1992. Identification of a gp63 surface glycoprotein in Leishmania tarentolae. FEMS Microbiol. Lett. 75: 89-92.
58. Lodge, R., and A. Descoteaux. 2008. Leishmania invasion and phagosome biogenesis. Subcell. Biochem. 47: 174-181.
59. Shio, M. T., K. Hassani, A. Isnard, B. Ralph, I. Contreras, M. A. Gómez, I. Abu-Dayyeh, and M. Olivier. 2012. Host cell signalling and leishmania mechanisms of evasion. J. Trop. Med. 2012: 819512.
60. Gueirard, P., A. Laplante, C. Rondeau, G. Milon, and M. Desjardins. 2008. Trafficking of Leishmania donovani promastigotes in non-lytic compartments in neutrophils enables the subsequent transfer of parasites to macrophages. Cell. Microbiol. 10: 100-111.
61. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-1506.
62. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-1147.
63. Dermine, J. F., G. Goyette, M. Houde, S. J. Turco, and M. Desjardins. 2005. Leishmania donovani lipophosphoglycan disrupts phagosome microdomains in J774 macrophages. Cell. Microbiol. 7: 1263-1270.
64. Winberg, M. E., A. Holm, E. Särndahl, A. F. Vinet, A. Descoteaux, K. E. Magnusson, B. Rasmusson, and M. Lerm. 2009. Leishmania donovani lipophosphoglycan inhibits phagosomal maturation via action on membrane rafts. Microbes Infect. 11: 215-222.